RU2008113043A - PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION - Google Patents
PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION Download PDFInfo
- Publication number
- RU2008113043A RU2008113043A RU2008113043/15A RU2008113043A RU2008113043A RU 2008113043 A RU2008113043 A RU 2008113043A RU 2008113043/15 A RU2008113043/15 A RU 2008113043/15A RU 2008113043 A RU2008113043 A RU 2008113043A RU 2008113043 A RU2008113043 A RU 2008113043A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- salt
- methyl
- stearic acid
- starch
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция с противомигреневым действием, включающая в качестве действующего вещества терапевтически эффективное количество гидрохлорида 3-(3,4,5-триметоксибензоилоксиимино)-8-метил-8-азабицикло [3,2,1] октана, а в качестве вспомогательных веществ, по меньшей мере, одно, выбранное из группы, включающей крахмал, лактозу, микрокристаллическую целлюлозу (МКЦ), аэросил, лудипресс, кальций фосфат двузамещенный, поливинилпирролидон, метилцеллюлозу, карбоксиметилцеллюлозу и ее натриевую соль, оксипропилцеллюлозу, оксипропилметилцеллюлозу, маннит, сорбит, стеариновую кислоту и/или ее соли и другие вспомогательные вещества, разрешенные к медицинскому применению. ! 2. Фармацевтическая композиция с противомигреневым действием, включающая в качестве действующего вещества гидрохлорид 3-(3,4,5-триметоксибензоилоксиимино)-8-метил-8-азабицикло [3,2,1] октана, а в качестве вспомогательных веществ - крахмал, стеариновую кислоту и/или ее соль, кальций фосфат двузамещенный при следующем соотношении компонентов, мас.%: ! Гидрохлорид 3 -(3,4,5-триметоксибензоилокси- имино)-8-метил-8-азабицикло [3,2,1] октана30,0-70,0Стеариновая кислота и/или ее соль1,0-1,3Кальция фосфат двузамещенный6,0-15,0КрахмалОстальное ! 3. Фармацевтическая композиция по п.2, отличающаяся тем, что в качестве крахмала она содержит крахмал картофельный. ! 4. Фармацевтическая композиция по п.2, отличающаяся тем, что в качестве соли стеариновой кислоты используется преимущественно магниевая соль. ! 5. Фармацевтическая композиция с противомигреневым действием, включающая в качестве действующего вещества гидрохлорид 3-(3,4,5-триметоксибензоилоксиимино)-8-метил-8-азабицикло [1. A pharmaceutical composition with anti-migraine action, comprising as the active substance a therapeutically effective amount of 3- (3,4,5-trimethoxybenzoyloxyimino) -8-methyl-8-azabicyclo [3,2,1] octane hydrochloride, and as excipients at least one selected from the group consisting of starch, lactose, microcrystalline cellulose (MCC), aerosil, ludipress, calcium phosphate disubstituted, polyvinylpyrrolidone, methyl cellulose, carboxymethyl cellulose and its sodium salt, hydroxypropyl cellulose, cellulose, mannitol, sorbitol, stearic acid and / or its salts and other auxiliary substances approved for medical use. ! 2. A pharmaceutical composition with anti-migraine action, comprising 3- (3,4,5-trimethoxybenzoyloxyimino) -8-methyl-8-azabicyclo [3,2,1] octane hydrochloride as an active ingredient, and starch as auxiliary substances, stearic acid and / or its salt, calcium phosphate disubstituted in the following ratio of components, wt.%:! Hydrochloride 3 - (3,4,5-trimethoxybenzoyloxy-imino) -8-methyl-8-azabicyclo [3.2.1] octane 30.0-70.0 Stearic acid and / or its salt 1.0-1.3 Calcium phosphate disubstituted6 0-15.0 Starch Else! 3. The pharmaceutical composition according to claim 2, characterized in that it contains potato starch as starch. ! 4. The pharmaceutical composition according to claim 2, characterized in that the predominantly magnesium salt is used as the stearic acid salt. ! 5. A pharmaceutical composition with anti-migraine action, comprising as active substance 3- (3,4,5-trimethoxybenzoyloxyimino) -8-methyl-8-azabicyclo hydrochloride [
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008113043/15A RU2424803C2 (en) | 2008-04-07 | 2008-04-07 | Pharmaceutical composition with antimigraine action (versions) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008113043/15A RU2424803C2 (en) | 2008-04-07 | 2008-04-07 | Pharmaceutical composition with antimigraine action (versions) |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2008113043A true RU2008113043A (en) | 2009-10-20 |
RU2424803C2 RU2424803C2 (en) | 2011-07-27 |
Family
ID=41262350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008113043/15A RU2424803C2 (en) | 2008-04-07 | 2008-04-07 | Pharmaceutical composition with antimigraine action (versions) |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2424803C2 (en) |
-
2008
- 2008-04-07 RU RU2008113043/15A patent/RU2424803C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2424803C2 (en) | 2011-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120202820A1 (en) | Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptin | |
RU2007148195A (en) | ORAL DOSED FORMS OF O-DESMETHYLVENENLAFXIN SUCCINATE OF INCREASED BIOAVAILABILITY WITH DELAYED DELIVERY | |
RU2015151938A (en) | TABLETABLE MEDICINE (4'-TRIFFORMETHYLPHENYL) AMID (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID WITH IMPROVED STABILITY | |
RU2011134964A (en) | PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITAZAR | |
RU2007119067A (en) | MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA | |
RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
RU2013126056A (en) | COMPOSITION FOR TREATMENT OF INVERVATION DISORDERS (OPTIONS) | |
RU2008113043A (en) | PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION | |
RU2628538C2 (en) | Composition including amlodipine and losartan having improved stability | |
RU2009101126A (en) | PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | |
RU2009114885A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
RU2007112544A (en) | PHARMACEUTICAL COMPOSITION HAVING ANTI-VESSEL AND PSYCHOTROPIC ACTION | |
RU2008147739A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2022107184A (en) | USE OF 1-(2-(1H-IMIDAZOL-4-YL)ETHYL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF COUGH CAUSED BY VIRAL INFECTIONS | |
RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
KR100593795B1 (en) | Formulations for oral administration containing ramipril with improved stability | |
RU2009134909A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2006142336A (en) | PHARMACEUTICAL COMPOSITION BASED ON LADASTEN | |
RU2006116540A (en) | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES | |
RU2008139377A (en) | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES | |
RU2009132616A (en) | PHARMACEUTICAL COMPOSITION OF LONG-TERM ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | |
RU2580303C1 (en) | Composition of pellet drug with proroxanum active ingredient | |
RU2007125596A (en) | COMBINED TUBERCULOSIS DRUG | |
RU2004118448A (en) | PHARMACEUTICAL COMPOSITION WITH PROLONGED GLYCLAZIDE RELEASE | |
RU2005110207A (en) | MUKOLITIC PHARMACEUTICAL COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner | ||
PD4A | Correction of name of patent owner |